Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Niti Aayog to bring blockchain technology for drug industry

      Niti Aayog to bring blockchain technology for drug industry

      Ruby Khatun Khatun4 Aug 2018 3:30 PM IST
      HYDERABAD: Niti Aayog is working with Apollo Hospitals and information technology major Oracle on applying blockchain (decentralized) technology in...
      TPG, KKR leading contenders to manage Abraajs healthcare fund: sources

      TPG, KKR leading contenders to manage Abraaj's healthcare fund: sources

      Ruby Khatun Khatun4 Aug 2018 10:15 AM IST
      DUBAI: Buyout firms TPG and KKR & Co have emerged as leading contenders to run Dubai-based private equity firm Abraaj's troubled $1 billion...
      Constellation Alpha Capital acquires diagnostic chain Medall for Rs 1450 crore

      Constellation Alpha Capital acquires diagnostic chain Medall for Rs 1450 crore

      Ruby Khatun Khatun4 Aug 2018 10:00 AM IST
      NEW YORK and CHENNAI, India: Constellation Alpha Capital Corp, a special purpose acquisition company focused on consolidating the healthcare services...
      Allergan sues Pfizer over costs of opioid litigation

      Allergan sues Pfizer over costs of opioid litigation

      Ruby Khatun Khatun4 Aug 2018 10:00 AM IST
      Allergan Plc on Thursday sued Pfizer Inc to require its rival to cover any damages it is forced to pay as a result of hundreds of lawsuits claiming...
      EU sees one in 5,000 cancer risk from valsartan

      EU sees one in 5,000 cancer risk from valsartan

      Ruby Khatun Khatun4 Aug 2018 9:45 AM IST
      LONDON: The European Medicines Agency estimates there could be one extra case of cancer for every 5,000 patients taking a common blood pressure and...
      Genzyme rare disease drug sales drive Sanofi profit

      Genzyme rare disease drug sales drive Sanofi profit

      Ruby Khatun Khatun4 Aug 2018 9:30 AM IST
      PARIS: Strong sales growth at Sanofi’s Genzyme rare diseases business drove better than expected second-quarter profit, allowing the French drugmaker...
      Remove Oxytocin Ban: Health Ministry Panel

      Remove Oxytocin Ban: Health Ministry Panel

      Ruby Khatun Khatun3 Aug 2018 6:12 PM IST
      New Delhi: The ban on the sale and manufacturing of the oxytocin formulations likely to lift up as the Drug Technical Advisory Board (DTAB) has...
      FDA approves first drug for rare adrenal tumors

      FDA approves first drug for rare adrenal tumors

      Ruby Khatun Khatun3 Aug 2018 10:45 AM IST
      The U.S. Food and Drug Administration (FDA) approved Azedra (iobenguane I 131) injection for intravenous use for the treatment of adults and...
      Pfizer Q1 profit rises 61 percent to Rs 92 crore

      Pfizer Q1 profit rises 61 percent to Rs 92 crore

      Ruby Khatun Khatun3 Aug 2018 10:30 AM IST
      New Delhi: Drug firm Pfizer reported 60.64% rise in standalone net profit to Rs 91.84 crore for the first quarter ended 30 June 2018-19.It had posted...
      Ugandas Cipla Quality Chemical Industries says plans IPO, listing

      Uganda's Cipla Quality Chemical Industries says plans IPO, listing

      Ruby Khatun Khatun3 Aug 2018 10:15 AM IST
      KAMPALA: Ugandan drugmaker Cipla Quality Chemical Industries Ltd said on Thursday it plans an initial public offering and a listing on the East...
      Daiichi Sankyo, Glycotope ink pact to develop Gatipotuzumab antibody drug conjugate

      Daiichi Sankyo, Glycotope ink pact to develop Gatipotuzumab antibody drug conjugate

      Ruby Khatun Khatun3 Aug 2018 10:00 AM IST
      New Delhi: Daiichi Sankyo Company, Limited and Glycotope GmbH have entered into an exclusive worldwide licensing agreement to develop an antibody-drug...
      Sanofi stockpiling more medicines in UK ahead of Brexit

      Sanofi stockpiling more medicines in UK ahead of Brexit

      Ruby Khatun Khatun3 Aug 2018 9:45 AM IST
      LONDON: Pharmaceutical company Sanofi has begun to stockpile more drugs in Britain than usual as part of contingency plans for delays in deliveries...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok